Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Back fat on MRI may reveal hidden bone and muscle risks

NCT ID NCT07238777

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 100 postmenopausal women aged 60-80 to see if the amount of fat in their back muscles is linked to bone density and muscle loss (sarcopenia). Researchers used MRI scans to measure back muscle fat and compared it with bone density tests and physical performance. The goal is to better understand how muscle and bone health are connected, which could help doctors spot problems earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

100 people

The number who actually took part.

Started

Apr 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

postmenopausal women aged 60-80 years

Ages

60 to 80 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female participants aged 60-80 years * Postmenopausal status * Lumbar MRI and DXA scan performed within the past six months * Willingness to participate and ability to provide written informed consent Exclusion Criteria: * History of lumbar spine surgery (e.g., laminectomy, stabilization) * Pfirrmann grade ≥4 lumbar disc degeneration on MRI¹³ * Secondary osteoporosis or Paget's disease * Use of walking aids or mobility restrictions * Neurological or systemic disorders affecting movement, including: * Parkinson's disease * Stroke * Amyotrophic lateral sclerosis (ALS) * Central or peripheral vertigo * Severe immobility or inability to complete performance tests * Presence of a hip prosthesis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sarcopenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beylikdüzü State Hospital

    Istanbul, Beylikdüzü, 34147, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.